US 12365723
Human plasma-derived IGG preparation enriched in anti-parvo B19 natural IGGS
granted A61KA61K2039/507A61P
Quick answer
US patent 12365723 (Human plasma-derived IGG preparation enriched in anti-parvo B19 natural IGGS) held by Takeda Pharmaceutical Company Limited expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jul 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/507, A61P, A61P25/28